The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.
If you would like to know how to access our trials please click here
Trial Name |
Description |
Click for more information (external page) |
RESMAIN |
Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.
|
|
PORT |
Phase 2 study testing the use of radiotherapy in addition to pembrolizumab for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma
|
|
CDK-003-101 |
A phase 1 trial of CDK-003 in patients with relapsed or refractory cutaneous T-cell lymphoma.
|
Sign up link will be added soon |
With special thanks to the following: